Press releases & Latest news
Isofol Receives Clinical Use Patent Approval in the United States for Drug Candidate arfolitixorin
Isofol Receives Clinical Use Patent Approval in the United States for Drug Candidate arfolitixorin GOTHENBURG, Sweden, June 25, 2019 –…
Isofol Announces Electionof Three New Board Members
Isofol Announces Election of Three New Board Members GOTHENBURG, Sweden, June 10, 2019 – Isofol Medical AB (publ) (Nasdaq First…
Isofol’s drug candidate arfolitixorin receives clinical patent approval in the United States
Isofol’s drug candidate arfolitixorin receives clinical patent approval in the United States GOTHENBURG, Sweden, May 21, 2019 – Isofol Medical…
Upcoming Events
- ESMO 2019, Barcelona, Spain
July 03, 2019 - July 06, 2019 - Financial report - second quarter, 2019
August 22, 2019 - August 22, 2019 - Danske Bank; Investor presentation, Stockholm, Sweden
August 22, 2019 - August 22, 2019